The Great Lawn, Long Branch
When you or someone you love hears the words “you have cancer”…
It’s one of the darkest moments in your life.
The light and warmth we generate delivers hope in time of despair, community in place of loneliness and life-saving RESEARCH & SUPPORT for cancer patients and their families.
We are taking steps to end cancer. WE Light The Night
The Leukemia & Lymphoma Society’s Light The Night Walk funds treatments that are saving the lives of patients today. LLS is making cures happen by providing patient support services, advocating for lifesaving treatments and pioneering the most promising cancer research anywhere. And it’s all happening now. Not someday, but today. Each year friends, families and coworkers form teams to raise money in support of our mission.
This year, in the fall, these teams and their communities Light The Night at our walks where we gather together to celebrate, honor and remember those touched by cancer.
It takes an army of volunteers to make Light The Night a successful and memorable event. Volunteers are needed for event planning, Walk night logistics and our Executive Committees. If you are interested in becoming a volunteer, please complete the form below. We welcome your support!
Light The Night raises funds in support of The Leukemia & Lymphoma Society (LLS).
The mission of LLS is: Cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families.
LLS exists to find cures and ensure access to treatments for blood cancer patients. We are the voice for all blood cancer patients and we work to ensure access to treatments for all blood cancer patients.
As there are no means of preventing or early screening for most blood cancers, the LLS research agenda is focused on finding cures. LLS drives research in areas of unmet medical need, and helps to bridge the gap between academic discovery and drug development. LLS identifies and funds the most promising blood cancer research projects and forges partnerships with academic institutions, biotechnology and pharmaceutical companies to accelerate the development of new therapies